{"id":9378,"date":"2026-03-17T16:15:37","date_gmt":"2026-03-17T15:15:37","guid":{"rendered":"https:\/\/fgk-group.com\/?post_type=knowledge-hub-mag&#038;p=9378"},"modified":"2026-03-17T16:18:57","modified_gmt":"2026-03-17T15:18:57","slug":"das-neue-fast-eu-programm-fuer-multinationale-klinische-studien","status":"publish","type":"knowledge-hub-mag","link":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/","title":{"rendered":"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"9378\" class=\"elementor elementor-9378\" data-elementor-post-type=\"knowledge-hub-mag\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d1cbeeb e-flex e-con-boxed e-con e-parent\" data-id=\"d1cbeeb\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7602641 elementor-widget elementor-widget-text-editor\" data-id=\"7602641\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong class=\"post_excerpt\">Im Sprint zum Studienstart in Europa: Mit dem Ende Januar 2026 gestarteten Pilotprogramm FAST\u2011EU (Facilitating and Accelerating Strategic Clinical Trials in the EU) setzen die Heads of Medicines Agencies (HMA) der EU ein klares Signal f\u00fcr eine schnellere klinische Entwicklung in Europa.<\/strong><\/p><p>Das Pilotprojekt soll zeigen, ob und wie die EU schnellere Entscheidungen zur Zulassung multinationaler klinischer Studien treffen kann, ohne dabei geltende Standards zu vernachl\u00e4ssigen. Auch BfArM und PEI unterst\u00fctzen das Pilotprogramm.<\/p><p>Bereits nach rund 70 Kalendertagen sollen Sponsoren eine finale beh\u00f6rdliche Entscheidung zu ihrem Studienantrag erhalten. Bislang dauert der Entscheidungsprozess erfahrungsgem\u00e4\u00df eher 100 bis 120 Tage.<\/p><p>Klingt ambitioniert? Ist es auch. Und dennoch alles andere als unrealistisch, auch vor dem Hintergrund, dass der EU Biotech Act perspektivisch ohnehin k\u00fcrzere und verl\u00e4sslichere Genehmigungszeiten vorsieht. Das Programm erf\u00e4hrt schon jetzt einen regelrechten Run an Antr\u00e4gen, die Chance f\u00fcr Sponsoren ist also real. Umso wichtiger ist es, sich jetzt mit den Teilnahmevoraussetzungen auseinanderzusetzen. Cornelia Grossrubatscher, Senior BD Manager bei FGK, erz\u00e4hlt mehr dazu auf <strong><a href=\"https:\/\/transkript.de\/hintergrund\/2026\/das-neue-fast%e2%80%91eu%e2%80%91programm-fuer-multinationale-klinische-studien\/\">transkript.de<\/a><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Im Sprint zum Studienstart in Europa: Mit dem Ende Januar 2026 gestarteten Pilotprogramm FAST\u2011EU (Facilitating and Accelerating Strategic Clinical Trials in the EU) setzen die Heads of Medicines Agencies (HMA) der EU ein klares Signal f\u00fcr eine schnellere klinische Entwicklung in Europa.<\/p>\n","protected":false},"featured_media":9379,"template":"","class_list":["post-9378","knowledge-hub-mag","type-knowledge-hub-mag","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien - FGK Group<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien - FGK Group\" \/>\n<meta property=\"og:description\" content=\"Im Sprint zum Studienstart in Europa: Mit dem Ende Januar 2026 gestarteten Pilotprogramm FAST\u2011EU (Facilitating and Accelerating Strategic Clinical Trials in the EU) setzen die Heads of Medicines Agencies (HMA) der EU ein klares Signal f\u00fcr eine schnellere klinische Entwicklung in Europa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/\" \/>\n<meta property=\"og:site_name\" content=\"FGK Group\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-17T15:18:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fgk-group.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-24.-Feb.-2026-10_05_33-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/\",\"url\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/\",\"name\":\"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien - FGK Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fgk-group.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/ChatGPT-Image-24.-Feb.-2026-10_05_33.png\",\"datePublished\":\"2026-03-17T15:15:37+00:00\",\"dateModified\":\"2026-03-17T15:18:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fgk-group.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/ChatGPT-Image-24.-Feb.-2026-10_05_33.png\",\"contentUrl\":\"https:\\\/\\\/fgk-group.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/ChatGPT-Image-24.-Feb.-2026-10_05_33.png\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Magazine\",\"item\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/knowledge-hub\\\/magazin\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/\",\"name\":\"FGK Group\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien - FGK Group","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/","og_locale":"de_DE","og_type":"article","og_title":"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien - FGK Group","og_description":"Im Sprint zum Studienstart in Europa: Mit dem Ende Januar 2026 gestarteten Pilotprogramm FAST\u2011EU (Facilitating and Accelerating Strategic Clinical Trials in the EU) setzen die Heads of Medicines Agencies (HMA) der EU ein klares Signal f\u00fcr eine schnellere klinische Entwicklung in Europa.","og_url":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/","og_site_name":"FGK Group","article_modified_time":"2026-03-17T15:18:57+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/fgk-group.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-24.-Feb.-2026-10_05_33-1024x683.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/","url":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/","name":"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien - FGK Group","isPartOf":{"@id":"https:\/\/fgk-group.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/#primaryimage"},"image":{"@id":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/#primaryimage"},"thumbnailUrl":"https:\/\/fgk-group.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-24.-Feb.-2026-10_05_33.png","datePublished":"2026-03-17T15:15:37+00:00","dateModified":"2026-03-17T15:18:57+00:00","breadcrumb":{"@id":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/#primaryimage","url":"https:\/\/fgk-group.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-24.-Feb.-2026-10_05_33.png","contentUrl":"https:\/\/fgk-group.com\/wp-content\/uploads\/2026\/03\/ChatGPT-Image-24.-Feb.-2026-10_05_33.png","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/das-neue-fast-eu-programm-fuer-multinationale-klinische-studien\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fgk-group.com\/de\/"},{"@type":"ListItem","position":2,"name":"Magazine","item":"https:\/\/fgk-group.com\/de\/knowledge-hub\/magazin\/"},{"@type":"ListItem","position":3,"name":"Das neue FAST\u2011EU\u2011Programm f\u00fcr multinationale klinische Studien"}]},{"@type":"WebSite","@id":"https:\/\/fgk-group.com\/de\/#website","url":"https:\/\/fgk-group.com\/de\/","name":"FGK Group","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fgk-group.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/knowledge-hub-mag\/9378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/knowledge-hub-mag"}],"about":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/types\/knowledge-hub-mag"}],"version-history":[{"count":5,"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/knowledge-hub-mag\/9378\/revisions"}],"predecessor-version":[{"id":9384,"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/knowledge-hub-mag\/9378\/revisions\/9384"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/media\/9379"}],"wp:attachment":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/media?parent=9378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}